|
|
|
|
RESEARCH |
|
|
|
|
|
In the aftermath of the Enron and WorldCom debacles, the traditional reach of Wall Street’s analyst coverage has been reduced drastically, disadvantaging a countless number of undiscovered companies. At present, more than 6,000 of the estimated 10,000 public companies do not have Wall Street analyst coverage. This lack of analyst coverage not only places a premium on quality independent research, but it also provides for significant opportunities across the entire stock universe. |
|
|
Our Value Based Trend Management®
(VBTM®) system uses both fundamental
and technical data to analyze individual
holdings or entire portfolios. Much of the method is based on mathematics and statistical models using a compilation of income statement data, modified PEG and Sharpe ratios in addition to more than 30 technical variables. |
 |
|
|
Our niche is in the need for thorough research projects completed outside of Wall Street's investment banking and retail agendas. We have reviewed numerous research reports from several research firms, and we are not aware of any firm that provides the amount of comprehensive fundamental and technical data that our research compiles. For example, our reports on Five Star Quality Care Incorporated (FVE) and Abraxis Bioscience Incorporated (ABBI) demonstrate our standards of research excellence. We protect the value of our research and avoid dilution by limiting access to our most desirable services.
Illuminant Capital’s services can be contracted on a per project basis or bundled into a multi-service retainer. The services we provide for our clients are on a highly confidential and non-distributed basis. Every aspect of our client relationships is kept strictly private. Integrity and ethical behavior are an essential part of our business strategy. To learn more about a specific service, contact Skyler Oates at (918) 693-1573 or through email: skyler.oates@illuminantcapital.com.
|
|
|
|
|
|
|

 |
|